| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917951 | Radiotherapy and Oncology | 2015 | 5 Pages |
Abstract
CIRT can be applied for primary epithelial carcinoma of the lacrimal gland, with a borderline acceptable morbidity and sufficient antitumor effect when an extended margin is adopted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nobutaka Mizoguchi, Hiroshi Tsuji, Shingo Toyama, Tadashi Kamada, Hirohiko Tsujii, Yuko Nakayama, Atsushi Mizota, Yoshitaka Ohnishi, Working Group for Ophthalmologic Tumors Working Group for Ophthalmologic Tumors,